The HI-Light Vitiligo Trial is a clinical trial involving 517 participants aged 5 years and over with vitiligo. The purpose of this study is to test the effectiveness of home-based light therapy using hand-held units and topical steroid for the treatment of vitiligo.
The study is being led by Dr Jonathan Batchelor and Professor Kim Thomas from the Centre of Evidence Based Dermatology at The University of Nottingham, and is being co-ordinated from the Nottingham Clinical Trials Unit.
We've finished recruiting for the Hi-light trial - thanks to those who got in touch. We're continuing to follow-up those who are taking part, and will put the results of the trial on this webpage when they're available.
For all other enquiries, please email hilight@nottingham.ac.uk
Vitiligo is a skin condition that causes white patches on the skin. It affects around 0.5%-1.0% of the population worldwide, both children and adults.
We are seeking 517 adults and children (from 5 years of age) across the UK with a few relatively small patches of vitiligo, and at least one patch that has appeared or has enlarged in the last 12 months.
Please neot recruitment has now ended.
Steroid ointment applied to the skin and home-based light therapy are the two treatments being tested in this study. These two treatments will be used alone or in combination, in order to see if combination treatment works better than either treatment alone.
In order to prevent anyone from guessing a participant’s treatment, dummy UVB devices and placebo steroid ointment will be used.
The trial is funded for just over 4 years, starting November 2014. We expect that recruitment will take up to 18 months and will start in late spring 2015.
Study participants use their treatments at home for 9 months, during which time they will visit their recruiting hospital every 3 months. They will also be asked to fill in some questionnaires at home. Once the treatment has been completed, we will stay in touch for another year so that you can tell us how the vitiligo is. Total involvement in the study is for 21 months.
The following hospitals were involved in recruiting patients into the HI-Light Vitiligo Trial:
October 2017 - Update written for the Vitiligo Society
February 2017 - BBC Inside out: HI-light vitiligo study featured January 2017 - HI-light recruitment target increased
Newsletter Issue 1 (Jan 2015)
Newsletter Issue 2 (Apr 2015)
Newsletter Issue 3 (Sep 2015)
Pilot HI-Light TrialHi-Light Protocol Development of the Vitiligo Noticeability Scale Validation of the Vitiligo Noticeability Scale
Disclaimer: This is an independent trial that is being funded by the National Institute for Health Research Health Technology Assessment Programme (Application Reference 12/24/02). The views expressed on this website are those of the author(s) and not necessarily those of the NIHR. The study has been developed with the help and support of the UK Dermatology Clinical Trials Network (UK DCTN). Based at the University of Nottingham, the UK DCTN is a collaborative group of over 700 dermatologists, nurses, primary care staff, health care researchers and patients/carers. The aim of the Network is simple – to develop independent, high quality randomised controlled clinical trials of interventions for the treatment or prevention of skin disease. For further information please see the UK DCTN website - www.ukdctn.org.
The University of Nottingham King's Meadow Campus Lenton Lane Nottingham, NG7 2NR
telephone: +44 (0) 115 823 1048 email:cebd@nottingham.ac.uk
Browser does not support script.